Category: atopic dermatitis

According to a new study, dietary changes may improve symptoms in patients with mild or moderate atopic dermatitis (AD) when used in conjunction with regular treatment. However, the authors note there are risks associated with elimination diets that should be discussed.

According to a new study, taking vitamin D supplements during pregnancy may reduce the likelihood of infants developing atopic dermatitis (AD) in their first year of life.

According to a new study, the prevalence of keratosis pilaris (KP) is low in patients with atopic dermatitis (AD).

According to a new study, depressive symptoms are closely linked to atopic dermatitis (AD) severity and can fluctuate alongside AD severity.

According to a new study, dupilumab shows safety and efficacy for up to four years in treatment of moderate-to-severe atopic dermatitis (AD) in adults.

According to a new study, patients with atopic dermatitis (AD) are more likely to achieve mild disease severity when treated with dupilumab and adjuvant tacrolimus as opposed to dupilumab alone.

Registration is open for the inaugural Atopic Dermatitis (AD) Summit. The virtual symposium will be held on Saturday, April 23, 2022, at 10:00 a.m. EDT.

A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis (AD).

According to a new study, dupilumab-induced ocular surface disease (DIOSD) appears to occur more frequently in patients with atopic dermatitis (AD) than in patients with other conditions being treated with the biologic.